ACETAMINOPHEN
POISONING
DR.SAHAR MIRZA
Resident peads
 Introduction
 Acetaminophen metabolism and toxicity
 Toxic dose
 Signs symptoms
 Stages
 Workup
 Management
 prevention
Acetaminophin
 Nsaid with potent anti pyretic, analgesic action
 Unintentionally ingested by young children
 Intentional overdose by adults
 Inappropriately dosed in all ages
Acetaminophen toxicity
 Results from the formation of a
HIGHLY REACTIVE INTERMEDIATE
METABOLITE
N-acetyl-p-benzoquinone imine (NAPQI)
NAPQI
 In therapeutic use:
 Small percentage of dose, 5% is metabolized
by hepatic cytochrome P450 enzyme to
NAPQI
 Which is immediately conjugated with
glutathione
 Form a nontoxic mercapturic acid conjugate
NAPQI
 In overdose :
 Glutathione stores are overwhelmed, and free
NAPQI is able to combine with hepatic
macromolecules to produce
HEPATOCELLULAR DAMAGE
Acute toxic dose of
acetaminophen
 The single acute toxic dose >200mg /kg in
children
 Supratherapeutic dose>75mg/kg/d can lead
to hepatic injury in some children,especially
in the setting of
Fever
Dehydration
Poor nutrition
Dec glutathione stores
Clinical and laboratory
manifestations
Investigations
 Serum APAP level should be measured 4hr
after reported time of ingestion
 Level obtained <4hr after ingestion cannot be
used to estimate potential toxicity
 Check levels 6-8 hours if it is co ingested with
other substance that slows GI motility ,
diphenhydramine
 Other BLI lfts, rfts, coagulation prrofile
RUMACK –MATTHEW nomogram
foa acetaminophen poisoning
 Any patient with serum acetamiophen level in
possible or probable hepatotoxicity range per
RM nomogram should be treated with
 N-ACETYLCYSTEINE
N=acetylcysteine
 Start NAC
 If acetaminophen level is above the treatment
line on Rumack-matthew nomogram
 If levels are low but LFTS dearrange
 If level is > 10microg/ml even with normal lfts
Treatment
 Initial treatment:
 Basic life support (ABCs)
 Decontamination with activated
charcaol(Within 1-2 hr of ingestion)
 The antidote for acetaminophen is N-
acetylcysteine
 MOA replenish hepatic glutathione stores
NAC
 Most effective when initiated within 8 hr of
ingestion
 NAC available both oral and iv
 DOSE ]ORAL :140mgKG loading,followed by
70mgkg every 4hr for 17 doses
 (MUCOMYST)
 DOSE IV:150mg/kg iv over 1 hr, followed by
50mg kg over 4 hours, followed by 100mg/kg
over 16 hrs
What is next
 A patient who is being on NAC , the following
lab test , lfts and rfts should be followed daily
 Patients who develop hepatic failure in spite o
NAC therapy may be candidates for liver
transplant
King’’s college criteria
 Are used to determine which patients should
be referred for consideration of liver transplant
1. Acidosis (Ph <7.3) after adequate fluid
resuscitation
2. Coagulopathy if Pt is more than 100 sec
3. Renal dysfunction (creatinine >3.4mg/dl
4. Hepatic encephalopathy grade 3/4
Prevention
 Inform and educate parents and caregivers
proper dosing and danger associated with
misusing varioius formulations
 Parents should always be given clear dose
and formulation instructions
 Based on age and weight
References
 Nelson
 Osama naga
 Webmd.com
Acetaminophen poisoning

Acetaminophen poisoning

  • 1.
  • 2.
     Introduction  Acetaminophenmetabolism and toxicity  Toxic dose  Signs symptoms  Stages  Workup  Management  prevention
  • 3.
    Acetaminophin  Nsaid withpotent anti pyretic, analgesic action  Unintentionally ingested by young children  Intentional overdose by adults  Inappropriately dosed in all ages
  • 4.
    Acetaminophen toxicity  Resultsfrom the formation of a HIGHLY REACTIVE INTERMEDIATE METABOLITE N-acetyl-p-benzoquinone imine (NAPQI)
  • 5.
    NAPQI  In therapeuticuse:  Small percentage of dose, 5% is metabolized by hepatic cytochrome P450 enzyme to NAPQI  Which is immediately conjugated with glutathione  Form a nontoxic mercapturic acid conjugate
  • 6.
    NAPQI  In overdose:  Glutathione stores are overwhelmed, and free NAPQI is able to combine with hepatic macromolecules to produce HEPATOCELLULAR DAMAGE
  • 7.
    Acute toxic doseof acetaminophen  The single acute toxic dose >200mg /kg in children  Supratherapeutic dose>75mg/kg/d can lead to hepatic injury in some children,especially in the setting of Fever Dehydration Poor nutrition Dec glutathione stores
  • 8.
  • 9.
    Investigations  Serum APAPlevel should be measured 4hr after reported time of ingestion  Level obtained <4hr after ingestion cannot be used to estimate potential toxicity  Check levels 6-8 hours if it is co ingested with other substance that slows GI motility , diphenhydramine  Other BLI lfts, rfts, coagulation prrofile
  • 10.
    RUMACK –MATTHEW nomogram foaacetaminophen poisoning  Any patient with serum acetamiophen level in possible or probable hepatotoxicity range per RM nomogram should be treated with  N-ACETYLCYSTEINE
  • 11.
    N=acetylcysteine  Start NAC If acetaminophen level is above the treatment line on Rumack-matthew nomogram  If levels are low but LFTS dearrange  If level is > 10microg/ml even with normal lfts
  • 12.
    Treatment  Initial treatment: Basic life support (ABCs)  Decontamination with activated charcaol(Within 1-2 hr of ingestion)  The antidote for acetaminophen is N- acetylcysteine  MOA replenish hepatic glutathione stores
  • 13.
    NAC  Most effectivewhen initiated within 8 hr of ingestion  NAC available both oral and iv  DOSE ]ORAL :140mgKG loading,followed by 70mgkg every 4hr for 17 doses  (MUCOMYST)  DOSE IV:150mg/kg iv over 1 hr, followed by 50mg kg over 4 hours, followed by 100mg/kg over 16 hrs
  • 14.
    What is next A patient who is being on NAC , the following lab test , lfts and rfts should be followed daily  Patients who develop hepatic failure in spite o NAC therapy may be candidates for liver transplant
  • 15.
    King’’s college criteria Are used to determine which patients should be referred for consideration of liver transplant 1. Acidosis (Ph <7.3) after adequate fluid resuscitation 2. Coagulopathy if Pt is more than 100 sec 3. Renal dysfunction (creatinine >3.4mg/dl 4. Hepatic encephalopathy grade 3/4
  • 16.
    Prevention  Inform andeducate parents and caregivers proper dosing and danger associated with misusing varioius formulations  Parents should always be given clear dose and formulation instructions  Based on age and weight
  • 17.